
Weltron SB 250mg/125mg Injection
Marketer
Martyn Nikk Pharma Private Limited
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Weltron SB 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. This injection requires administration by a healthcare professional; strictly adhere to the prescribed dosage schedule. Complete the entire course of treatment, regardless of symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects to your physician immediately. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals should consult their physician prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occur. Adequate rest, balanced nutrition, and ample hydration are crucial for optimal recovery. Your doctor may order blood tests and other diagnostics to monitor treatment response.
Uses of Weltron SB 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Weltron SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Weltron SB 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Weltron SB 250mg/125mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How Weltron SB 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Weltron SB 250mg/125mg Injection, offer a dual-action approach to bacterial infection. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with concurrent alcohol and Weltron SB 250mg/125mg Injection use.
PregnancySAFE IF PRESCRIBED
The injectable medication, Weltron SB 250mg/125mg, is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human subjects remain scarce.
Breast feedingCAUTION
Administering Weltron SB 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Weltron SB 250mg/125mg Injection could lead to reduced alertness, visual disturbances, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Weltron SB 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Weltron SB 250mg/125mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician. Dosage alteration for Weltron SB 250mg/125mg Injection is unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Weltron SB 250mg/125mg Injection :
Should you inadvertently omit a dose of Weltron SB 250mg/125mg Injection, seek immediate medical advice.
Facts to Know About Weltron SB 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
